-
Sector Analysis
Germany Telecom Operators Country Intelligence Report
Germany Telecom Operators Country Intelligence Overview The total telecom and pay-TV service revenue in Germany increased to $44.5 billion in 2023. The market size growth has been estimated to progress at a CAGR of more than 3% during 2023-2028, driven by constant developments in fixed broadband and mobile data segments. The Germany Telecom Services market growth is also attributed to the Gigabit Strategy 2030 initiative aimed to expand FTTH/B and mobile broadband, including 5G network expansion to half the population...
-
Thematic Analysis
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 – Top Themes and Predictions – Thematic Intelligence
Global Tech, Media, and Telecom (TMT) M&A Deals 2023 Theme and Predictions Report Overview Total M&A deal value in the technology, media, and telecom (TMT) sector declined 46% in 2023, compared to the previous year. Software and services accounted for over 48% share of the total M&A deal value in 2023. The ‘Global Tech, Media, And Telecom (TMT) M&A Deals 2023 Theme and Predictions Report’ analyzes the top disruptive themes that drove M&A activity in the technology, media, and telecom (TMT)...
-
Thematic Analysis
Digital Marketing Trends in Non-small Cell Lung Cancer
Digital Marketing Trends in Non-small Cell Cancer Report Overview Merck’s Keytruda.com achieved the highest total traffic across Non-small Cell Lung Cancer (NSCLC) patient sites in the US from October 2022 to September 2023. This was followed by BMS's Opdivo.com and AstraZeneca's Imfinzi.com. Keytruda.com was also supported by the most paid search engine optimization (SEO) at over 7,600 keywords, closely followed by Enhertu.com and Opdivo.com. Overall, the highest proportion of traffic to top branded patient NSCLC websites originated from direct and organic sources. The Digital...
-
Track & Monitor
5G in technology: Wireless traffic scheduling
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the technology industry’s Wireless traffic scheduling segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Cloud in technology: Virtual network traffic routing
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the technology industry’s Virtual network traffic routing segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Sector Analysis
Americas Mobile Broadband Market Trends and Opportunities to 2028
Americas Mobile Broadband Market Trends and Opportunities Report Overview The mobile service revenue in the Americas is estimated to be $285 billion in 2023 and is expected to grow at a CAGR of more than 2% during 2023-2028. 5G network expansion efforts by operators in North America and in Latin America will generate new opportunities for digital service providers, towercos, and infrastructure and telecom equipment vendors. Operators can also drive revenue growth through higher ARPU 5G mobile plans. Americas Mobile...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FHD-286 in Chronic Myelomonocytic Leukemia (CMML)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FHD-286 in Chronic Myelomonocytic Leukemia (CMML) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.FHD-286 in Chronic Myelomonocytic Leukemia (CMML) Drug Details: FHD-286 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FHD-286 in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FHD-286 in Myelodysplastic Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FHD-286 in Myelodysplastic Syndrome Drug Details: FHD-286 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FHD-286 in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FHD-286 in Refractory Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FHD-286 in Refractory Acute Myeloid Leukemia Drug Details: FHD-286 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FHD-286 in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FHD-286 in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FHD-286 in Relapsed Acute Myeloid Leukemia Drug Details: FHD-286 is...